HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuta Kodama Selected Research

cligosiban

9/2021Oxytocin receptor is a promising therapeutic target of malignant mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuta Kodama Research Topics

Disease

3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 01/2019
2Neoplasms (Cancer)
09/2021 - 01/2020
1Neoplasm Metastasis (Metastasis)
06/2022
1Malignant Mesothelioma
09/2021
1Lung Neoplasms (Lung Cancer)
04/2020

Drug/Important Bio-Agent (IBA)

1ErbB Receptors (EGF Receptor)IBA
06/2022
1Tyrosine Kinase InhibitorsIBA
06/2022
1osimertinibIBA
06/2022
1Oxytocin Receptors (Oxytocin Receptor)IBA
09/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
09/2021
1Hormones (Hormone)IBA
09/2021
1Messenger RNA (mRNA)IBA
09/2021
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
09/2021
1cligosibanIBA
09/2021
1Oxytocin (Pitocin)FDA LinkGeneric
09/2021
1Biomarkers (Surrogate Marker)IBA
04/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020
1Bevacizumab (Avastin)FDA Link
01/2020
1PlatinumIBA
01/2020
1AfatinibIBA
01/2019

Therapy/Procedure

1Oral Administration
09/2021
1Drug Therapy (Chemotherapy)
01/2020